This is Andrew Pollack’s recent story on Gilead’s new $130 per pill (use daily) for pulmonary arterial hypertension. The price of this drug, which is a once daily pill, is roughly the average per capita income in the United States, leaving nothing else for food, housing, clothing or having a beer at the local bar.